128 related articles for article (PubMed ID: 31756005)
1. Association of insurance type with time course of care in head and neck cancer management.
Itamura K; Kokot N; Sinha U; Swanson M
Laryngoscope; 2020 Nov; 130(11):E587-E592. PubMed ID: 31756005
[TBL] [Abstract][Full Text] [Related]
2. Gatekeeping and patterns of outpatient care post healthcare reform.
Barnett ML; Song Z; Bitton A; Rose S; Landon BE
Am J Manag Care; 2018 Oct; 24(10):e312-e318. PubMed ID: 30325192
[TBL] [Abstract][Full Text] [Related]
3. Patterns of Multidisciplinary Care of Head and Neck Squamous Cell Carcinoma in Medicare Patients.
Hansen CC; Egleston B; Leachman BK; Churilla TM; DeMora L; Ebersole B; Bauman JR; Liu JC; Ridge JA; Galloway TJ
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1136-1146. PubMed ID: 33090191
[TBL] [Abstract][Full Text] [Related]
4. A contemporary analysis of racial disparities in recommended and received treatment for head and neck cancer.
Nocon CC; Ajmani GS; Bhayani MK
Cancer; 2020 Jan; 126(2):381-389. PubMed ID: 31580491
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated With the Choice of Radiation Therapy Treatment Facility in Head and Neck Cancer.
Sullivan CB; Al-Qurayshi Z; Anderson CM; Seaman AT; Pagedar NA
Laryngoscope; 2021 May; 131(5):1019-1025. PubMed ID: 32846018
[TBL] [Abstract][Full Text] [Related]
6. HMO or PPO: picking a managed-care plan.
Consum Rep; 2003 Oct; 68(10):35-9. PubMed ID: 14513826
[No Abstract] [Full Text] [Related]
7. Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):85-92. PubMed ID: 30252608
[TBL] [Abstract][Full Text] [Related]
8. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer.
Graboyes EM; Garrett-Mayer E; Sharma AK; Lentsch EJ; Day TA
Cancer; 2017 Jul; 123(14):2651-2660. PubMed ID: 28241092
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with adjuvant treatment delays in patients treated surgically for head and neck cancer.
Sticker AL; Cannon ST; Russell GB; Waltonen JD
Clin Otolaryngol; 2024 Jul; 49(4):445-452. PubMed ID: 38610122
[TBL] [Abstract][Full Text] [Related]
10. Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer.
Graboyes EM; Cagle JL; Ramadan S; Prasad K; Yan F; Pearce J; Mazul AL; Anoma JS; Hill EG; Chera BS; Puram SV; Jackson R; Sandulache VC; Tam S; Topf MC; Kahmke R; Osazuwa-Peters N; Nussenbaum B; Alberg AJ; Sterba KR; Halbert CH
JAMA Otolaryngol Head Neck Surg; 2024 Jun; 150(6):472-482. PubMed ID: 38662392
[TBL] [Abstract][Full Text] [Related]
11. Impact of insurance on survival in patients < 65 with head & neck cancer treated with radiotherapy.
Sittig MP; Luu M; Yoshida EJ; Scher K; Mita A; Shiao SL; Lu DJ; Mallen-St Clair J; Ho AS; Zumsteg ZS
Clin Otolaryngol; 2020 Jan; 45(1):63-72. PubMed ID: 31661188
[TBL] [Abstract][Full Text] [Related]
12. Direct health-care cost of head and neck cancers: a population-based study in north-eastern Italy.
Polesel J; Lupato V; Collarile P; Vaccher E; Fanetti G; Giacomarra V; Palazzari E; Furlan C; Matrone F; Navarria F; Gobitti C; Minatel E; Serraino D; Birri S; Franchin G
Med Oncol; 2019 Feb; 36(4):31. PubMed ID: 30815763
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
[TBL] [Abstract][Full Text] [Related]
14. Costs and survival of patients with colorectal cancer in a health maintenance organization and a preferred provider organization.
Kerrigan M; Howlader N; Mandelson MT; Harrison R; Mansley EC; Ramsey SD
Med Care; 2005 Oct; 43(10):1043-8. PubMed ID: 16166874
[TBL] [Abstract][Full Text] [Related]
15. Disability outcomes of older Medicare HMO enrollees and fee-for-service Medicare beneficiaries.
Porell FW; Miltiades HB
J Am Geriatr Soc; 2001 May; 49(5):615-31. PubMed ID: 11380756
[TBL] [Abstract][Full Text] [Related]
16. Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database.
Zandberg DP; Cullen K; Bentzen SM; Goloubeva OG
Oral Oncol; 2018 Nov; 86():132-140. PubMed ID: 30409293
[TBL] [Abstract][Full Text] [Related]
17. Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma.
Jin MC; Harris JP; Sabolch AN; Gensheimer M; Le QT; Beadle BM; Pollom EL
Laryngoscope; 2020 Nov; 130(11):E598-E604. PubMed ID: 31837165
[TBL] [Abstract][Full Text] [Related]
18. Insurance access in adults with congenital heart disease in the Affordable Care Act era.
Lin CJ; Novak E; Rich MW; Billadello JJ
Congenit Heart Dis; 2018 May; 13(3):384-391. PubMed ID: 29480975
[TBL] [Abstract][Full Text] [Related]
19. Volumetric changes in pharyngeal structures following head and neck cancer chemoradiation therapy.
Hinther A; Samson N; Lau H; Quon H; Banerjee R; Lysack JT; Grendarova P; Matthews TW; Randall DR
Laryngoscope; 2020 Mar; 130(3):597-602. PubMed ID: 31260128
[TBL] [Abstract][Full Text] [Related]
20. The "Medicare effect" on head and neck cancer diagnosis and survival.
Smith JB; Jayanth P; Hong SA; Simpson MC; Massa ST
Head Neck; 2023 Jul; 45(7):1663-1675. PubMed ID: 37096786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
